FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS

dc.contributor.author	Kurbonova Nozima Sobirjonovna
dc.date.accessioned	2025-12-31T15:35:59Z
dc.date.issued	2022-03-13
dc.description.abstract	The main components of the treatment of type 2 diabetes mellitus (DM) are hypoglycemic, lipid-lowering and antihypertensive therapy, while endocrinologists traditionally perceive the first of these components as the most important. Based on the results of several large prospective studies, it was concluded that compensation of type 2 diabetes close to normoglycemia is accompanied by an improvement in long-term prognosis in terms of the risk of macrovascular complications and death from cardiovascular diseases.
dc.format	application/pdf
dc.identifier.uri	https://scholarexpress.net/index.php/wbph/article/view/651
dc.identifier.uri	https://asianeducationindex.com/handle/123456789/48865
dc.language.iso	eng
dc.publisher	Scholar Express Journals
dc.relation	https://scholarexpress.net/index.php/wbph/article/view/651/598
dc.rights	https://creativecommons.org/licenses/by-nc-nd/4.0
dc.source	World Bulletin of Public Health; Vol. 8 (2022): WBPH; 67-72
dc.source	2749-3644
dc.subject	Glycemic component
dc.subject	to normoglycemia
dc.subject	dyslipidemia
dc.title	FACTORS DETERMINING THE CLINICAL SIGNIFICANCE OF DEPIPTIDYL PEPTIDASE 4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
dc.type	info:eu-repo/semantics/article
dc.type	info:eu-repo/semantics/publishedVersion
dc.type	Peer-reviewed Article

item.page.files

pagination.showing.labelpagination.showing.detail

item.page.filesection.name: sobirjonovna_2022_factors_determining_the_clinical_signifi.pdf
item.page.filesection.size: 194.04 KB
item.page.filesection.format: Adobe Portable Document Format